Skip to content
  • Sunday, 26 July 2026
  • 2:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma
Laboratory Automation & Robotics

Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma

Lana Keisha Jul 2, 2026 0

As Peter Gassner, CEO of Veeva Systems, the long-established cloud software provider dominating the life sciences industry, prepared to take…

Read More
Laboratory Automation & Robotics

Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma

Lana Keisha Jun 24, 2026 0

Boston, MA – As Peter Gassner, CEO of Veeva Systems, a dominant cloud software provider in the life sciences sector,…

Read More
Laboratory Automation & Robotics

Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma

Lana Keisha Jun 16, 2026 0

In a significant move underscoring the escalating competition in the life sciences technology sector, Salesforce announced that over 140 life…

Read More
Laboratory Automation & Robotics

Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma

Lana Keisha Jun 2, 2026 0

In a strategic maneuver that underscores the intensifying competition in the life sciences technology sector, Salesforce has announced that over…

Read More
Closing the Information Gap: ETH Zürich Team Integrates Function and Binding in One Drug Screening AssayTWiV 1286: Clinical update with Dr. Daniel GriffinTWiV 1287: Ancient Herpesviruses and Modern DementiaA Novel DNA Test Revolutionizes Root Biomass Quantification and Unlocks Deeper Insights into Plant Carbon Storage
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ